Literature DB >> 17468927

The prognostic significance of total lymph node harvest in patients with T2-4N0M0 colorectal cancer.

Hsiang-Lin Tsai1, Chien-Yu Lu, Jan-Sing Hsieh, Deng-Chyang Wu, Chang-Ming Jan, Chee-Yin Chai, Koung Shing Chu, Hon-Man Chan, Jaw-Yuan Wang.   

Abstract

In patients with radically resected colorectal carcinoma, lymph node involvement is particularly important for a good prognosis and adjuvant therapy. The number of such lymph node recoveries is still controversial, with recommendations ranging from 6 to 17 nodes. The aim of this study is to determine if a specified minimum number of lymph nodes examined per surgical specimen can have any effect on the prognosis of patients who have undergone curative resection for T(2-4)N(0)M(0) colorectal carcinoma. Between September 1999 and January 2005, a total of 366 patients who underwent radical resection for T(2-4)N(0)M(0) colorectal carcinoma were retrospectively analyzed in a single institution. All specimen segments were fixed, with node identification performed by sight and palpation. We excluded 186 patients who received postoperative adjuvant chemotherapy via oral or intravenous transmission to prevent possible chemotherapeutic effects on patients' prognosis; therefore, a total of 180 patients with T(2-4)N(0)M(0) colorectal carcinoma were enrolled into this study. After the pathological examination, a mean of 12 lymph nodes (range 0-66) was harvested per tumor specimen. No postoperative relapse was found in this group, where the number of examined lymph nodes was 18 or more. Univariate analysis identified the size of the tumor, depth of invasion, grade of tumor, and number of examined lymph nodes, which were significantly correlated with postoperative relapse (all P < 0.05). Meanwhile, both the depth of tumor invasion and the number of harvested lymph nodes were independent predictors for postoperative relapse (P < 0.05). The 5-year overall survival rate of T(2-4)N(0)M(0) colorectal carcinoma patients who had 18 or more lymph nodes examined was significantly higher than those who had less than 18 nodes examined (P = 0.015). Nodal harvest in patients undergoing radical resection for colorectal carcinoma was highly significant in the current investigation. Our results suggest that harvesting and examining a minimum of 18 lymph nodes per surgical specimen might be taken into consideration for more reliable staging of lymph node-negative colorectal carcinoma.

Entities:  

Mesh:

Year:  2007        PMID: 17468927     DOI: 10.1007/s11605-007-0119-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.267


  23 in total

1.  Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer.

Authors:  Masaya Mukai; Shinkichi Sato; Tomomi Nishida; Nobukazu Komatsu; Kazuaki Shiba; Hisao Nakasaki; Hiroyasu Makuuchi
Journal:  Oncol Rep       Date:  2003 Nov-Dec       Impact factor: 3.906

2.  Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT).

Authors:  L P Fielding; P A Arsenault; P H Chapuis; O Dent; B Gathright; J D Hardcastle; P Hermanek; J R Jass; R C Newland
Journal:  J Gastroenterol Hepatol       Date:  1991 Jul-Aug       Impact factor: 4.029

3.  Clinical-pathologic staging of large-bowel cancer. A report of the ASCRS Committee.

Authors:  L P Fielding
Journal:  Dis Colon Rectum       Date:  1988-03       Impact factor: 4.585

4.  Number of nodes examined and staging accuracy in colorectal carcinoma.

Authors:  J H Wong; R Severino; M B Honnebier; P Tom; T S Namiki
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

5.  Five-year follow-up study of the fat clearance technique in colorectal carcinoma.

Authors:  K W Scott; R H Grace; P Gibbons
Journal:  Dis Colon Rectum       Date:  1994-02       Impact factor: 4.585

6.  Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer.

Authors:  V C Petersen; K J Baxter; S B Love; N A Shepherd
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

7.  Clinical and pathological prognostic indicators with colorectal mucinous carcinomas.

Authors:  Keisuke Kubota; Takayuki Akasu; Shin Fujita; Ken-ichi Sugihara; Yoshihiro Moriya; Seiichiro Yamamoto
Journal:  Hepatogastroenterology       Date:  2004 Jan-Feb

8.  A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients.

Authors:  Frederick L Greene; Andrew K Stewart; H James Norton
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969

9.  Detection of lymph node metastases in colorectal carcinoma before and after fat clearance.

Authors:  K W Scott; R H Grace
Journal:  Br J Surg       Date:  1989-11       Impact factor: 6.939

10.  Adequacy of nodal harvest in colorectal cancer: a consecutive cohort study.

Authors:  Paul M Johnson; Dickram Malatjalian; Geoff A Porter
Journal:  J Gastrointest Surg       Date:  2002 Nov-Dec       Impact factor: 3.267

View more
  35 in total

1.  Lymph node harvest in colon and rectal cancer: Current considerations.

Authors:  James R McDonald; Andrew G Renehan; Sarah T O'Dwyer; Najib Y Haboubi
Journal:  World J Gastrointest Surg       Date:  2012-01-27

2.  Patterns of lymph node metastasis are different in colon and rectal carcinomas.

Authors:  Hao Wang; Xian-Zhao Wei; Chuan-Gang Fu; Rong-Hua Zhao; Fu-Ao Cao
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

3.  Extended lymphadenectomy in colon cancer is crucial.

Authors:  Hermann Kessler; Werner Hohenberger
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

4.  Overexpression of matrix metalloproteinase 9 in tumor epithelial cells correlates with colorectal cancer metastasis.

Authors:  David S Zuzga; Ahmara Vivian Gibbons; Peng Li; Wilhelm Johannes Lubbe; Inna Chervoneva; Giovanni Mario Pitari
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689

5.  Prognostic factors for patients with stage II colon cancer: results of a prospective study.

Authors:  Chenghai Zhang; Jiabo Di; Beihai Jiang; Ming Cui; Zaozao Wang; Jiadi Xing; Hong Yang; Zhendan Yao; Nan Zhang; Xiangqian Su
Journal:  Int J Colorectal Dis       Date:  2016-01       Impact factor: 2.571

Review 6.  Colorectal cancer and lymph nodes: the obsession with the number 12.

Authors:  Giovanni Li Destri; Isidoro Di Carlo; Roberto Scilletta; Beniamino Scilletta; Stefano Puleo
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

7.  Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute.

Authors:  Chun-Chi Lin; Jen-Kou Lin; Shih-Ching Chang; Huann-Sheng Wang; Shung-Haur Yang; Jeng-Kai Jiang; Wei-Shone Chen; Tzu-Chen Lin
Journal:  Int J Colorectal Dis       Date:  2009-02-24       Impact factor: 2.571

8.  Predicting factors of postoperative relapse in T2-4N0M0 colorectal cancer patients via harvesting a minimum of 12 lymph nodes.

Authors:  Hsiang-Lin Tsai; Yung-Sung Yeh; Fang-Jung Yu; Chien-Yu Lu; Chin-Fan Chen; Chao-Wen Chen; Yu-Tang Chang; Jaw-Yuan Wang
Journal:  Int J Colorectal Dis       Date:  2008-10-14       Impact factor: 2.571

9.  The optimal number of lymph nodes examined in stage II colorectal cancer and its impact of on outcomes.

Authors:  Hok Kwok Choi; Wai Lun Law; Jensen T C Poon
Journal:  BMC Cancer       Date:  2010-06-08       Impact factor: 4.430

10.  Preoperative chemoradiotherapy does not necessarily reduce lymph node retrieval in rectal cancer specimens--results from a prospective evaluation with extensive pathological work-up.

Authors:  Thilo Sprenger; Hilka Rothe; Kia Homayounfar; Tim Beissbarth; B Michael Ghadimi; Heinz Becker; Torsten Liersch
Journal:  J Gastrointest Surg       Date:  2009-10-15       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.